- Main
Inhibition of RNA splicing triggers CHMP7 nuclear entry, impacting TDP-43 function and leading to the onset of ALS cellular phenotypes
- Al-Azzam, Norah;
- To, Jenny;
- Gautam, Vaishali;
- Street, Lena;
- Nguyen, Chloe;
- Naritomi, Jack;
- Lam, Dylan;
- Madrigal, Assael;
- Lee, Benjamin;
- Jin, Wenhao;
- Avina, Anthony;
- Mizrahi, Orel;
- Mueller, Jasmine;
- Ford, Willard;
- Schiavo, Cara;
- Rebollo, Elena;
- Vu, Anthony;
- Blue, Steven;
- Madakamutil, Yashwin;
- Manor, Uri;
- Rothstein, Jeffrey D;
- Coyne, Alyssa;
- Jovanovic, Marko;
- Yeo, Gene W
Published Web Location
https://doi.org/10.1016/j.neuron.2024.10.007Abstract
Amyotrophic lateral sclerosis (ALS) is linked to the reduction of certain nucleoporins in neurons. Increased nuclear localization of charged multivesicular body protein 7 (CHMP7), a protein involved in nuclear pore surveillance, has been identified as a key factor damaging nuclear pores and disrupting transport. Using CRISPR-based microRaft, followed by gRNA identification (CRaft-ID), we discovered 55 RNA-binding proteins (RBPs) that influence CHMP7 localization, including SmD1, a survival of motor neuron (SMN) complex component. Immunoprecipitation-mass spectrometry (IP-MS) and enhanced crosslinking and immunoprecipitation (CLIP) analyses revealed CHMP7's interactions with SmD1, small nuclear RNAs, and splicing factor mRNAs in motor neurons (MNs). ALS induced pluripotent stem cell (iPSC)-MNs show reduced SmD1 expression, and inhibiting SmD1/SMN complex increased CHMP7 nuclear localization. Crucially, overexpressing SmD1 in ALS iPSC-MNs restored CHMP7's cytoplasmic localization and corrected STMN2 splicing. Our findings suggest that early ALS pathogenesis is driven by SMN complex dysregulation.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.